{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "37000-815",
      "generic_name": "acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, and phenylephrine hydrochloride",
      "labeler_name": "The Procter & Gamble Manufacturing Company",
      "brand_name": "Vicks NyQuil Severe Cold and Flu",
      "brand_name_suffix": "Severe Cold and Flu",
      "active_ingredients": [
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "10 mg/30mL"
        },
        {
          "name": "DOXYLAMINE SUCCINATE",
          "strength": "12.5 mg/30mL"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "20 mg/30mL"
        },
        {
          "name": "ACETAMINOPHEN",
          "strength": "650 mg/30mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "37000-815-08",
          "description": "236 mL in 1 BOTTLE, PLASTIC (37000-815-08)",
          "marketing_start_date": "20140721",
          "sample": false
        },
        {
          "package_ndc": "37000-815-12",
          "description": "354 mL in 1 BOTTLE, PLASTIC (37000-815-12)",
          "marketing_start_date": "20140721",
          "sample": false
        },
        {
          "package_ndc": "37000-815-36",
          "description": "3 BOTTLE, PLASTIC in 1 PACKAGE, COMBINATION (37000-815-36)  / 354 mL in 1 BOTTLE, PLASTIC (37000-815-12)",
          "marketing_start_date": "20140721",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SOLUTION",
      "spl_id": "5d2cd7bb-d2cf-bda3-e063-6394a90a19f7",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20140721",
      "product_id": "37000-815_5d2cd7bb-d2cf-bda3-e063-6394a90a19f7",
      "application_number": "M012",
      "brand_name_base": "Vicks NyQuil",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Antihistamine [EPC]",
        "Histamine Receptor Antagonists [MoA]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}